Edinburgh Research Explorer

Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland

Research output: Contribution to journalArticle

Standard

Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. / Tonner, E; Allan, G; Shkreta, L; Webster, J; Whitelaw, C B; Flint, D J.

In: Advances in Experimental Medicine and Biology, Vol. 480, 2000, p. 45-53.

Research output: Contribution to journalArticle

Harvard

Tonner, E, Allan, G, Shkreta, L, Webster, J, Whitelaw, CB & Flint, DJ 2000, 'Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland', Advances in Experimental Medicine and Biology, vol. 480, pp. 45-53.

APA

Tonner, E., Allan, G., Shkreta, L., Webster, J., Whitelaw, C. B., & Flint, D. J. (2000). Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. Advances in Experimental Medicine and Biology, 480, 45-53.

Vancouver

Tonner E, Allan G, Shkreta L, Webster J, Whitelaw CB, Flint DJ. Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. Advances in Experimental Medicine and Biology. 2000;480:45-53.

Author

Tonner, E ; Allan, G ; Shkreta, L ; Webster, J ; Whitelaw, C B ; Flint, D J. / Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. In: Advances in Experimental Medicine and Biology. 2000 ; Vol. 480. pp. 45-53.